Vaginal DNA Assay Shows Promise - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

  • By

  • Kerri Miller

  • May 8, 2026

  • 14 min

Share

Original Source(s)

Vaginal DNA Assay Shows Promise

  • by Kerri Miller

  • May 8, 2026

Related Content

Survival beyond treatment: patterns and determinants of disease-free survival in cervical cancer at a tertiary care center in India

A prospective surgical evaluation of the coexistence of endometriosis and interstitial cystitis/bladder pain syndrome

Cancer prevalence in the United States: trends and sociodemographic disparities based on national health interview survey data (2019–2023)